JMS Co

JMS Co Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of JMS Co (7702.T) as of Nov 2, 2026 is 104.82. In the previous year, Cash Conversion Cycle (CCC) was 177.13 — a change of -40.83% (lower).

Cash Conversion Cycle

104.82

YoY

-40.83%

Last updated:

Cash Conversion Cycle (CCC) of JMS Co is 2026 104.82 . Cash Conversion Cycle (CCC) of JMS Co was 2025 177.13 . It decreases by -40.83% lower compared to the previous year.

The JMS Co Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2019
141.84 JPY
Jan 1, 2020
148.60 JPY
Jan 1, 2021
167.16 JPY
Jan 1, 2022
157.86 JPY
Jan 1, 2023
154.99 JPY
Jan 1, 2024
167.74 JPY
Jan 1, 2025
177.13 JPY
Jan 1, 2026
104.82 JPY
The JMS Co Cash Conversion Cycle history
YEARCash Conversion CycleYoY
104.82-40.83%
177.13+5.60%
167.74+8.23%
154.99-1.82%
157.86-5.56%
167.16+12.49%
148.60+4.76%
141.84-2.54%
145.54+5.92%
137.40-22.29%
176.81-6.70%
189.50+28.00%
148.05—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

Cash Conversion Cycle (CCC) of JMS Co is 104.82 in 2026.

Cash Conversion Cycle (CCC) of JMS Co changed from 177.13 to 104.82, representing a -40.83% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) JMS Co since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s JMS Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — JMS Co

All Key Metrics — JMS Co